Investigating the molecular mechanisms underlying the co-occurrence of Parkinson’s disease and inflammatory bowel disease through the integration of multiple datasets
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Investigating the molecular mechanisms underlying the co-occurrence of Parkinson’s disease and inflammatory bowel disease through the integration of multiple datasets ; volume:14 ; number:1 ; day:24 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (24.7.2024), 1-14, 12.2024
- Urheber
-
Sun, Qi
Li, Yi-Jun
Ning, Shou-Bin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-67890-1
- URN
-
urn:nbn:de:101:1-2410100716177.302611301550
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sun, Qi
- Li, Yi-Jun
- Ning, Shou-Bin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The dimensionality of fatigue in Parkinson’s disease
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
The dimensionality of fatigue in Parkinson’s disease
Quantitative validation of CFD simulations of blood flow in cerebral aneurysms : in-vitro and in-vivo investigations
Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
Responsiveness of the short-form health survey and the Parkinson’s disease questionnaire in patients with Parkinson’s disease
The neurophysiological brain-fingerprint of Parkinson’s disease
Cannabinoids in the Treatment of Parkinson’s Disease
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate